🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to investigate the significance of minimal residual axillar...
Status
Completed
Location
Multiple Locations
Start Date
2006-09-01
Trial ID
NCT06149884
Treatments Being Tested
The potential of the administration of indocyanine green (ICG) allows the e...
Status
Unknown
Location
Ginecologia e Ostetricia
Start Date
2020-07-09
Trial ID
NCT04663412
The purpose of this trial is to show adequate assay performance on clinical...
Status
Completed
Location
Indiana University Hospital
Start Date
2007-10
Trial ID
NCT00551278
Treatments Being Tested
The purpose of this study is to analyze the average direct costs of each of...
Status
Completed
Location
Hôpital privé des Peupliers
Start Date
2023-02-23
Trial ID
NCT05699291
Treatments Being Tested
The aim of the study is to compare one-step nucleic acid amplification meth...
Status
Completed
Location
Faculty Hospital in Pilsen
Start Date
2016-03
Trial ID
NCT02826291
Treatments Being Tested
Epithelial ovarian cancer (EOC) remains the tumour with the most unfavourab...
Status
Unknown
Location
Maastricht UMC
Start Date
2022-06-01
Trial ID
NCT05375526
Treatments Being Tested
The aim of this study is to evaluate the Sentimag/Sienna+ System (Sentimag®...
Status
Completed
Location
The Royal Wolverhampton NHS Trust
Start Date
2016-09-22
Trial ID
NCT02739425
Treatments Being Tested
Sentinel lymph node dissection (SLND) after NAC, aimed to reduce the rate o...
Status
Unknown
Location
ICO - Site ANGERS
Start Date
2019-01-08
Trial ID
NCT03630913
Treatments Being Tested
This study is designed to collect data about the amount of time required to...
Status
Terminated
Location
Cedars-Sinai Medical Center
Start Date
2007-12
Trial ID
NCT00595023
Treatments Being Tested
RATIONALE: Interferon alfa-2b may interfere with the growth of cancer cells...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
1999-10
Trial ID
NCT00004196
Treatments Being Tested